Literature DB >> 1425133

Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.

J M van Gerven1, J P Boot, H H Lemkes, J A van Best.   

Abstract

The morphological base for the impaired function of the blood retinal barrier was studied in 50 eyes of 10 insulin dependent and 21 non-insulin dependent patients with various levels of diabetic retinopathy. The permeability of the blood retinal barrier (PBRB) was determined by vitreous fluorophotometry with correction for autofluorescence, lens transmission and non-protein bound plasma fluorescein concentration. Morphological abnormalities of diabetic retinopathy assessed by fundus photography and fluorescein angiography were individually scored on a decimal scale and related to the PBRB by multiple regression analysis. The PBRB was not correlated to morphological abnormalities of non-proliferative retinopathy [(1) microaneurysms, (2) hard exudates, (3) soft exudates, (4) intraretinal hemorrhages, (5) fluorescein leakage, and (6) capillary closure, p greater than 0.3]. The PBRB was correlated to morphological abnormalities of (pre)proliferative retinopathy [(1) intraretinal microvascular abnormalities (SIRMA) and (2) new vessels (Sneo): PBRB = A+B.SIRMA + C.Sneo with PBRB in nm/sec, A = 1.5 +/- 0.5, B = 0.9 +/- 0.2 and C = 1.7 +/- 0.4, R2 = 0.65, p less than 0.0001]. It can be concluded that the increased blood retinal barrier permeability in diabetic patients is mainly due to (pre)proliferative abnormalities and not to non-proliferative abnormalities.

Entities:  

Mesh:

Year:  1992        PMID: 1425133     DOI: 10.1007/bf00161244

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  20 in total

1.  Blood aqueous barrier permeability versus age by fluorophotometry.

Authors:  J A van Best; J P Kappelhof; L Laterveer; J A Oosterhuis
Journal:  Curr Eye Res       Date:  1987-07       Impact factor: 2.424

2.  The correlation of the results of vitreous fluorophotometry and fluorescein angiography in nonproliferative diabetic retinopathy.

Authors:  M Stur; A Reitner; K Irsigler
Journal:  Retina       Date:  1988       Impact factor: 4.256

3.  Inward permeability of the blood-retinal barrier by fluorophotometry.

Authors:  J P Kappelhof; J A van Best; P L van Valenberg; J A Oosterhuis
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-04       Impact factor: 4.799

4.  Evidence for functional endothelial cell damage in early diabetic retinopathy.

Authors:  M Porta; C Townsend; G M Clover; M Nanson; A R Alderson; A McCraw; E M Kohner
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

5.  Early breakdown of the blood-retinal barrier in diabetes.

Authors:  J Cunha-Vaz; J R Faria de Abreu; A J Campos
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

6.  Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy.

Authors:  J J Kjaergaard; V Ohrt
Journal:  Int J Microcirc Clin Exp       Date:  1983

7.  Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.

Authors:  S R Waltman
Journal:  Trans Am Ophthalmol Soc       Date:  1984

8.  The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.

Authors:  T C Prager; H H Chu; C A Garcia; R E Anderson; J B Field; E A Orzeck; J P Comstock
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-01       Impact factor: 4.799

9.  Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.

Authors:  P Chahal; T J Fallon; S J Jennings; P J Chowienczyk; E M Kohner
Journal:  Diabetes Care       Date:  1986 Mar-Apr       Impact factor: 19.112

10.  Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.

Authors:  J G Cunha-Vaz; J R Gray; R C Zeimer; M C Mota; B M Ishimoto; E Leite
Journal:  Diabetes       Date:  1985-01       Impact factor: 9.461

View more
  3 in total

1.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

2.  Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.

Authors:  B Sander; M Larsen; C Engler; C Strøm; B Moldow; N Larsen; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

3.  Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.

Authors:  J M van Gerven; J P Boot; H H Lemkes; J A van Best
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.